INSERM UMR 991, Rennes, France.
Hepatology. 2011 Jun;53(6):1895-905. doi: 10.1002/hep.24290. Epub 2011 May 2.
Drug-induced liver injury occurs in general after several weeks and is often unpredictable. It is characterized by a large spectrum of lesions that includes steatosis and phospholipidosis. Many drugs such as amiodarone and tetracycline have been reported to cause phospholipidosis and/or steatosis. In this study, acute and chronic hepatic effects of these two drugs were investigated using well-differentiated human hepatoma HepaRG cells. Accumulation of typical lipid droplets, labeled with Oil Red O, was observed in hepatocyte-like HepaRG cells after repeat exposure to either drug. Amiodarone caused the formation of additional intracytoplasmic vesicles that did not stain in all HepaRG cells. At the electron microscopic level, these vesicles appeared as typical lamellar bodies and were associated with an increase of phosphatidylethanolamine and phosphatidylcholine. A dose-dependent induction of triglycerides (TG) was observed after repeat exposure to either amiodarone or tetracycline. Several genes known to be related to lipogenesis were induced after treatment by these two drugs. By contrast, opposite deregulation of some of these genes (FASN, SCD1, and THSRP) was observed in fat HepaRG cells induced by oleic acid overload, supporting the conclusion that different mechanisms were involved in the induction of steatosis by drugs and oleic acid. Moreover, several genes related to lipid droplet formation (ADFP, PLIN4) were up-regulated after exposure to both drugs and oleic acid.
Our results show that amiodarone causes phospholipidosis after short-term treatment and, like tetracycline, induces vesicular steatosis after repeat exposure in HepaRG cells. These data represent the first demonstration that drugs can induce vesicular steatosis in vitro and show a direct relationship between TG accumulation and enhanced expression of lipogenic genes.
药物性肝损伤通常在数周后发生,且往往不可预测。其特征为病变谱广泛,包括脂肪变性和磷脂沉积。已有报告显示,胺碘酮和四环素等许多药物可引起磷脂沉积和/或脂肪变性。在这项研究中,我们使用分化良好的人肝癌 HepaRG 细胞研究了这两种药物的急性和慢性肝效应。重复暴露于这两种药物后,可观察到类肝细胞 HepaRG 细胞中典型的脂滴积累,油红 O 标记。胺碘酮导致在所有 HepaRG 细胞中未染色的细胞内囊泡形成。在电子显微镜水平,这些囊泡表现为典型的板层小体,并与磷脂酰乙醇胺和磷脂酰胆碱增加相关。重复暴露于胺碘酮或四环素后,可观察到三酰甘油(TG)的剂量依赖性诱导。这些药物处理后,一些已知与脂肪生成相关的基因被诱导。相比之下,在油酸过载诱导的脂肪 HepaRG 细胞中,这些基因中的一些(FASN、SCD1 和 THSRP)的表达出现相反的下调,这支持了药物和油酸诱导脂肪变性的不同机制的结论。此外,在暴露于这两种药物和油酸后,一些与脂滴形成相关的基因(ADFP、PLIN4)被上调。
我们的结果表明,胺碘酮在短期治疗后引起磷脂沉积,并且与四环素类似,在 HepaRG 细胞中重复暴露后引起囊泡性脂肪变性。这些数据首次证明药物可在体外诱导囊泡性脂肪变性,并显示 TG 积累与增强的脂肪生成基因表达之间存在直接关系。